NO853441L - Fremgangsmaate for fremstilling av benzofuransulfonamider. - Google Patents

Fremgangsmaate for fremstilling av benzofuransulfonamider.

Info

Publication number
NO853441L
NO853441L NO853441A NO853441A NO853441L NO 853441 L NO853441 L NO 853441L NO 853441 A NO853441 A NO 853441A NO 853441 A NO853441 A NO 853441A NO 853441 L NO853441 L NO 853441L
Authority
NO
Norway
Prior art keywords
benzofuransulphonamides
procedure
preparation
dihydrobenzofuran
parenterally
Prior art date
Application number
NO853441A
Other languages
English (en)
Other versions
NO169487C (no
NO169487B (no
Inventor
Hiroshi Harada
Yoshihiro Matsushita
Masuhisa Nakamura
Yukio Yonetani
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NO853441L publication Critical patent/NO853441L/no
Publication of NO169487B publication Critical patent/NO169487B/no
Publication of NO169487C publication Critical patent/NO169487C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO853441A 1984-09-05 1985-09-02 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,3-dihydrobenzofuran-5-sulfonamider NO169487C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59186971A JPS6163671A (ja) 1984-09-05 1984-09-05 ２，３−ジヒドロベンゾフラン−５−スルホンアミド誘導体および降圧利尿剤

Publications (3)

Publication Number Publication Date
NO853441L true NO853441L (no) 1986-03-06
NO169487B NO169487B (no) 1992-03-23
NO169487C NO169487C (no) 1992-07-01

Family

ID=16197928

Family Applications (1)

Application Number Title Priority Date Filing Date
NO853441A NO169487C (no) 1984-09-05 1985-09-02 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,3-dihydrobenzofuran-5-sulfonamider

Country Status (15)

Country Link
US (1) US4659709A (no)
EP (1) EP0173899B1 (no)
JP (1) JPS6163671A (no)
KR (1) KR930002100B1 (no)
AT (1) ATE70534T1 (no)
AU (1) AU592060B2 (no)
CA (1) CA1265800A (no)
DE (1) DE3584919D1 (no)
DK (1) DK165954C (no)
GB (1) GB2164039B (no)
IE (1) IE58911B1 (no)
NO (1) NO169487C (no)
NZ (1) NZ213197A (no)
PT (1) PT81033B (no)
ZA (1) ZA856277B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116874A (en) * 1985-09-23 1992-05-26 Eli Lilly And Company Anti-tumor method and compounds
JPH01100164A (ja) * 1987-10-12 1989-04-18 Shionogi & Co Ltd スルファモイル−２−ベンゾフランカルボン酸誘導体
DE3861963D1 (de) * 1987-12-24 1991-04-11 Boehringer Mannheim Gmbh Heterocyclisch substituierte alkylsulfonamide, verfahren zu ihrer herstellung sowie arzneimittel.
GB9110636D0 (en) * 1991-05-16 1991-07-03 Glaxo Group Ltd Chemical compounds
US5254582A (en) * 1992-02-05 1993-10-19 Eli Lilly And Company Antitumor compositions and methods
US5387681A (en) * 1992-08-19 1995-02-07 Eli Lilly And Company Synthesis of bicyclic aromatic sulfonic acids sulfonyl chlorides and sulfonamides
US6150402A (en) * 1994-08-15 2000-11-21 Loma Linda University Medical Center Natriuretic compounds
DE10135499A1 (de) * 2001-07-20 2003-01-30 Merck Patent Gmbh Indanverbindungen mit negativem Delta-epsilon
US7795242B2 (en) * 2003-10-15 2010-09-14 The Brigham And Women's Hospital, Inc. Methods and compositions for immunomodulation
HUE039584T2 (hu) 2004-10-29 2019-01-28 Kalypsys Inc PPAR-modulátor szulfonil-szubsztituált biciklusos vegyületek
HUE040020T2 (hu) * 2005-10-25 2019-02-28 Kalypsys Inc PPAR modulátorok sói és eljárások metabolikus betegségek kezelésére
US20080176861A1 (en) 2007-01-23 2008-07-24 Kalypsys, Inc. Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6004073A (en) * 1972-09-09 1975-03-06 Basf Ag Fluorescent benzofuran compounds
US4401669A (en) * 1978-01-27 1983-08-30 Merck & Co., Inc. 2,3-Dihydro-substituted-5-benzoyl benzofuran-2-carboxylic acids and their use in treating hypertension
CA1145758A (en) * 1979-05-16 1983-05-03 Shell Canada Limited 2,3-dihydro-2-benzofurancarboxamide derivatives
US4237130A (en) * 1979-06-21 1980-12-02 Merck & Co., Inc. 2,3-Dihydro-6,7-disubstituted-5-(substituted sulfonyl)benzofuran-2-carboxylic acids
DE3317884A1 (de) * 1983-05-17 1984-11-22 Hoechst Ag, 6230 Frankfurt 5-(4-chlor-3-sulfamoylbenzoyl)-2,3-dihydro-2-benzofurancarbonsaeuren und verfahren zu ihrer herstellung
US4544667A (en) * 1984-02-09 1985-10-01 Merck & Co., Inc. 2-Sulfamoylbenzo[b]furan derivatives for the treatment of elevated intraocular pressure

Also Published As

Publication number Publication date
PT81033A (en) 1985-09-01
GB2164039A (en) 1986-03-12
ZA856277B (en) 1986-04-30
ATE70534T1 (de) 1992-01-15
EP0173899A2 (en) 1986-03-12
CA1265800A (en) 1990-02-13
US4659709A (en) 1987-04-21
DE3584919D1 (de) 1992-01-30
AU4621585A (en) 1986-03-13
PT81033B (pt) 1987-09-18
NO169487C (no) 1992-07-01
NO169487B (no) 1992-03-23
JPH0354945B2 (no) 1991-08-21
DK403185D0 (da) 1985-09-04
DK165954B (da) 1993-02-15
IE852188L (en) 1986-03-05
GB8521967D0 (en) 1985-10-09
KR860002490A (ko) 1986-04-26
JPS6163671A (ja) 1986-04-01
AU592060B2 (en) 1990-01-04
EP0173899A3 (en) 1988-07-20
NZ213197A (en) 1989-01-06
DK403185A (da) 1986-03-06
KR930002100B1 (ko) 1993-03-26
IE58911B1 (en) 1993-12-01
DK165954C (da) 1993-07-05
EP0173899B1 (en) 1991-12-18
GB2164039B (en) 1988-05-18

Similar Documents

Publication Publication Date Title
IT1164548B (it) Forme galeniche di somministrazione di medicamenti per via orale,a liberazione programmata,e loro procedimenti di preparazione
NO853441L (no) Fremgangsmaate for fremstilling av benzofuransulfonamider.
IT1270594B (it) Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
FR2602425B1 (fr) Forme d'administration orale a activite systemique de la carbamazepine (5h-dibenzo(b,f)azepine-5-carboxamide), sa preparation et ses utilisations therapeutiques
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
MY117090A (en) Substituted benzamidines, their preparation and their use as pharmaceutical compounds
NO860424L (no) Fremgangsmaate ved fremstilling av 6-thioxanthinderivater.
SE9002500L (sv) Farmaceutisk, nac-innehaallande komposition foer oral administrering
GB1503675A (en) Compositions based on pyrimidine derivatives and their use in the treatment of viral infections
EP0157267A3 (en) Substituted benzopyrans, process for their preparation and their use in medicines
AU4827085A (en) Method for treatment of antidiuresis employing serine derivatives
MY102991A (en) Medicaments for treating hypertension.
BR9710377A (pt) Gr-nulos de derivados de hexahidropirazina administr veis por via oral
ES8802372A1 (es) Procedimiento para preparar un agente que contiene tirosina o un derivado de tirosina como sustancia activa para mejorar la fecundidad de mamiferos.
GB1518042A (en) Oxadiazolinone derivatives
IE832255L (en) Treatment of herpes labialis.
MY100938A (en) Arylkylimidazole derivatives.
IE820676L (en) Pharmaceutical preparation
GB1511196A (en) Creatinine pyrolidonecarboxylate
FI74003B (fi) Foerfarande foer framstaellning av en terapeutiskt anvaendbar 5,14-dihydrobens/5,6/isoindolo/2,1-b/isokinolin- 8,13-dion.
GB1465794A (en) Thiourea derivatives
IT1224250B (it) Associzione del depiprazolo con la morfina
GB1442619A (en) 3-phenoxypropylamine derivatives their preparation and use
ES2018387A6 (es) Procedimiento de obtencion de un medicamento para inhibir la infeccion de celulas por virus hiv.
JPS5231226A (en) Exhaust-gas reflux system